XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.23.2

Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee | 6 Months Ended |
--- | --- | ---
Jun. 30, 2023 | Dec. 31, 2022
Braingenesis Biotechnology Co., Ltd. [Member] |  |
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items] |  |
Ownership percentage | 0.22% | 0.22%
Accounting treatments | Cost Method |
Genepharm Biotech Corporation [Member] |  |
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items] |  |
Ownership percentage | 0.92% | 0.92%
Accounting treatments | Cost Method |
BioHopeKing Corporation [Member] |  |
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items] |  |
Ownership percentage | 8.03% | 8.03%
Accounting treatments | Cost Method |
BioFirst Corporation [Member] |  |
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items] |  |
Ownership percentage | 21.77% | 21.77%
Accounting treatments | Equity Method |
Rgene Corporation [Member] |  |
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items] |  |
Ownership percentage | 28.85% | 28.85%
Accounting treatments | Equity Method |

X
- Definition Description of the accounting treatment. for example : It records the sale of assets and payment of liabilities and realisation expenditures. + References No definition available. + Details
Name: | abvc_AccountingTreatmentDescription
Namespace Prefix: | abvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | abvc_LongTermInvestmentsDetailsScheduleofOwnershipPercentagesofInvesteeLineItems
Namespace Prefix: | abvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Ownership percentage. + References No definition available. + Details
Name: | abvc_OwnershipPercentage
Namespace Prefix: | abvc_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_GenepharmBiotechCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |